Status:

COMPLETED

Therapeutic Efficacy of Intravenous Lidocaine Infusion Compared With Epidural Analgesia for Postoperative Pain Control in Adult Patients Undergoing Major Abdominal Surgery: Non-Inferiority Clinical Trial

Lead Sponsor:

Universidad de Antioquia

Collaborating Sponsors:

IPS Universitaria-Universidad de Antioquia

Conditions:

Pain, Postoperative

Opioid Use

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Major abdominal surgery continues is one of the most performed surgical procedures in the world, both electively and urgently. One of the main problems of this type of intervention is postoperative pa...

Eligibility Criteria

Inclusion

  • Patient over 18 years.
  • Elective major open intra-abdominal surgery:
  • Cholecystectomy.
  • Total or subtotal gastrectomy.
  • Colectomy or Hemicolectomy.
  • Pancreatoduodenectomy.
  • Hepatectomy 1 or 2 segments.
  • Exploration and / or reconstruction of the bile duct.
  • Abdominal demolition.
  • Sigmoidectomy.
  • Patient classified as ASA (American Association of Anesthesiology) 1, 2 or 3.

Exclusion

  • Pregnant woman
  • Patient with contraindication for epidural analgesic techniques:
  • Anticoagulated patient
  • Active infection in the puncture site.
  • Malformation in spinal cord.
  • Sepsis without antibiotic treatment.
  • Patient with contraindication for the use of intravenous lidocaine: Arrhythmias of any type not treated.
  • Patient with known allergy to opioids and / or local anesthetics.
  • Patient with chronic pain in previous management with strong opioids, gabapentinoids or epidural technique.
  • Patient with liver failure or terminal renal failure.
  • Patient who is scheduled for intubated admission to an intensive care unit after the procedure.
  • Patient who refuses to participate in the study or who refuses to receive epidural analgesia.
  • Patient who was technically impossible to place an epidural catheter in surgery.

Key Trial Info

Start Date :

March 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 5 2022

Estimated Enrollment :

210 Patients enrolled

Trial Details

Trial ID

NCT04017013

Start Date

March 1 2020

End Date

September 5 2022

Last Update

September 26 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Antioquias Univervesity Health Institution

Medellín, Antioquia, Colombia